Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001317845 | SCV001508523 | uncertain significance | Carnitine palmitoyl transferase 1A deficiency | 2022-03-12 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 17 of the CPT1A gene. It does not directly change the encoded amino acid sequence of the CPT1A protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs777779540, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with CPT1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 1018533). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235548 | SCV003934804 | uncertain significance | not specified | 2023-05-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001317845 | SCV002092940 | uncertain significance | Carnitine palmitoyl transferase 1A deficiency | 2020-12-03 | no assertion criteria provided | clinical testing |